Status:
COMPLETED
Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Blepharitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of AzaSite ophthalmic solution, 1% on signs and symptoms of blepharitis.
Eligibility Criteria
Inclusion
- diagnosis of moderate to severe chronic posterior blepharitis
- if female of childbearing potential, are non-pregnant and non-lactating
Exclusion
- had ocular surface surgery (LASIK, refractive, etc.) within the past year
- unwilling to discontinue use of contact lenses during the study
- have glaucoma
- unable or unwilling to withhold the use of lid scrubs during the study
- have a serious systemic disease or uncontrolled medical condition that in the judgment of the investigator could confound study assessments or limit compliance
- currently using any preserved topical ocular medications (with the exception of unpreserved tear substitutes) at the time of entry into the study or during study participation
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00629590
Start Date
March 1 2008
Last Update
September 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Shore Eye Care
Wantagh, New York, United States, 11793